—

Hinge Health, Inc.(HNGE)— 同業公司組

數據截至2026-11-02 — 評分每個交易日晚間重新計算。分組標準=首先為共同的Closelook指數成分,其次為產業。Closelook研究日記,不構成投資建議。

Hinge Health, Inc.的Closelook綜合評分為56/100,在同業公司組內排名第7位(共8家)——組內評分最高的是Halozyme Therapeutics Inc(73/100)。

名稱綜合動能品質估值訊號距52週高點
HNGE Hinge Health, Inc.56986321ok2.8%
HQY HealthEquity Inc62777040ok3.7%
VEEV Veeva Systems Inc Class A61967527bull4%
TEM Tempus AI, Inc. Class A Common Stock41831916bear30.8%
HALO Halozyme Therapeutics Inc73979438ok3.8%
DXCM DexCom Inc66788038watch11.1%
ONC BeiGene, Ltd.64836430info7%
ARGX argenx NV ADR63687429info18.4%

評分為Closelook全部涵蓋範圍內的相對讀數——方法論詳見公司評分說明。訊號燈來自每日夜間訊號看板。

FAQ · from the current data · as of 2026-11-02

Quick answers

Hinge Health, Inc.在Closelook涵蓋範圍內的同業公司有哪些?

分組首先根據共同的Closelook指數成分,其次根據產業:HealthEquity Inc (HQY)、Veeva Systems Inc Class A (VEEV)、Tempus AI, Inc. Class A Common Stock (TEM)、Halozyme Therapeutics Inc (HALO)、DexCom Inc (DXCM)、BeiGene, Ltd. (ONC)、argenx NV ADR (ARGX)。

HNGE相對同業公司的評分如何?

Hinge Health, Inc.的綜合評分為56/100,組內排名第7位(共8家),截至2026-11-02;組內最高綜合評分為Halozyme Therapeutics Inc(73/100)。Closelook評分為研究日記讀數,不構成評等或投資建議。

Related in the Closelooknet universe

then Health Information Services, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.